Infant's Life Was Saved by Cannabis, Mom Claims A

New Post Public Reply Private Reply Replies (1) Message Board
john1234

Infant's Life Was Saved by Cannabis, Mom Claims

A Florida single mother of four announced this week that she believes a strain of cannabis has saved the life of her youngest child, 19-month-old Nettie, after doctors said that no more could be done to keep her alive. “Nettie was going to die,” Rachael Garner told Yahoo Health about her daughter. “I feel 100 percent sure it has saved her life.”

Nettie — who was born with cerebral palsy and hydrocephalus (a buildup of fluid on the brain), which was causing frequent seizures — was hospitalized with two strains of pneumonia in June, when doctors said she would soon die. On July 2, Garner started her daughter on a rogue treatment plan of cannabidiol, or CBD, which is a non-psychoactive, THC-free marijuana compound; it had been sent to her gratis, from California-based provider Stephen Carmen, of Carmen CBD Oils, who found Nettie’s story on Facebook. Garner, a 33-year-old certified pharmacy technician (currently not working) who reads medical journals and was familiar with stories about CBD and seizures, readily accepted. And 24 hours after the first treatment, which involves administering drops under the tongue, Garner noticed a remarkable turnaround in Nettie

“I picked her up, and instead of being scared, like she usually is, she smiled,” Garner recalled. “Later, she cooed, and she’s never been verbal.” She added that it was like “a miracle,” she said — particularly since she had lost another child, 10-month-old Raquel, to the same condition about a year before Nettie was born.

While Nettie’s story is still ongoing — she’s been sick with chest congestion lately, although she’s remained seizure free since that first dose, and her family is raising money for medical expenses — hers is just one of many that point to CBD as a viable treatment for seizures. This past year has seen much coverage of families who have flocked to Colorado, one of 23 states where medical marijuana is legal (with more pending), and where there have been reports of CBD helping children with Dravet Syndrome, which can cause constant, life-threatening seizures. As of May, according to the Gazette, 180 children in Colorado were taking the oil, with thousands more on a waiting list.
Still, while anecdotes about CBD’s effectiveness have been extremely hopeful, they seem to remain just that — anecdotes.
“It seems to work on some, and seems to definitely not work on others,” Michael Backes, marijuana researcher and author of the forthcoming “Cannabis Pharmacy,” told Yahoo Health. “The long-term developmental effects on children are not well understood, so while it may relieve symptoms now, we don’t know what it might do down the line.” Backes recognized that “desperate parents with desperately ill children are desperate for relief,” but added, “I just want to make sure no kids are hurt down the road. Even though it’s not psychoactive, CBD is a powerful drug.”

Studies are underway, though, and preliminary findings have been “encouraging,” Backes said. Orrin Devinsky, an epilepsy expert with the NYU Langone Medical Center in New York, is a leading researcher in the field. In May, he co-authored a study in the journal Epilepsia that found, “Pure CBD appears to be an ideal candidate among phytocannabinoids as a therapy for treatment-resistant epilepsy.” He made a case for further research, noting it would make sense to “systematically investigate the safety, pharmacokinetics, and interactions of CBD with other antiepileptic drugs and obtain an initial signal regarding efficacy at different dosages. These data can then be used to plan double-blinded placebo-controlled efficacy trials.”

In Colorado Springs, Colorado, Dr. Margaret Gedde is a physician who has been tracking the young CBD patients there. Of the 47 patients who started taking the oil this fall, 28 percent reported more than 80 percent reduction in seizures, she told the Gazette. Another 49 percent reported some reduction in seizures and several other benefits, while 23 percent stopped using the oil because it was either ineffective or detrimental. “This is what is called anecdotal evidence, but it is also very real,” said Gedde. “We have 78 percent of patients benefiting from this. Often it allows them to get off more dangerous medications. Clearly it has a role in treating epilepsy.”

Carmen, Rachael’s supplier, is also a big believer in the anecdotes — so much so, in fact, that he has dedicated his life to getting the oil to people who need it. While living in Utah last year, he tried to get CBD for his father, who had liver cancer, because he had read about it being an effective treatment, he told Yahoo Health. But it was impossible to get in his state, and after his father died, he said, “I was so infuriated that I packed everything I had and moved to California.”

That’s where he said he met a biochemist who makes the oils — at a cost of $97.50 per 10 ml, which equates to about a one-month supply — and the two formed a nonprofit. Now, in addition to selling the product, Carmen logs onto Facebook daily, searching for families who are in need, like Nettie’s, to whom they can donate the treatments. He said they’ve seen successes with many illnesses, from lupus to cancer, adding, “It blows my mind every day.”

In Florida, where the Garners live, citizens will get to vote on the issue of legalizing medical marijuana through a ballot measure in November. But Gov. Rick Scott signed the Charlotte’s Web bill into law in June, legalizing the use of CBD to treat conditions from epilepsy to Lou Gehrig’s disease. The bill was named after Charlotte Figi, a 7-year-old Colorado girl who had her seizures effectively treated with the oil. A bipartisan bill of the same name was introduced on July 28 to the U.S. House of Representatives, possibly paving the way for CBD to be legal on a national level.

Still, the Florida law won’t go into effect until Jan. 1, 2015, so instead of waiting it out, Garner chose to accept Carmen’s offer. They both believe she will be protected under the law on the grounds of religious freedom, as she belongs to a Native American church that regards cannabis as “a sacrament.” And Garner’s belief in the powers of the oil is too strong for her to give it up anyway. “I’m not going to lose her to this, I’m just not,” she said. “I’ve already had one casualty.”

reference
https://www.yahoo.com/health/infants-life-was...99772.html

Rightsmile Inc. (RIGH) Stock Research Links

RIGH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
A Teen's Opera Encounter Inspires Decades of Passion

Updated Category News Views 0

Unraveling a Lifelong Opera Obsession Back in the dog-eared days of 1970, a teenager waltzed into the Metropolitan Opera and stumbled onto a passion that'd pulse alongside him for over half a century. Now, David E. Lapin rolls out his personal chronicle, 'A Sound Obsession: Fifty-Five Years of Opera at the Met.' Folks, we’re diving into a cultural tapestry that’s...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 145

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 146

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 279

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 88

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 86

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 7

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 37

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 87

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Piper Sandler Welcomes John Kerins to Healthcare Team

Updated Category News Views 218

Piper Sandler Expands Healthcare Investment Banking Expertise Piper Sandler Companies (NYSE: PIPR), a prominent name in investment banking, is excited to announce a significant addition to their healthcare investment banking team with the hiring of John Kerins as a managing director. This strategic move reflects the firm’s commitment to strengthening its presence in the...

Continue Reading
Exploring North America's Last Mile Delivery Growth and Trends

Updated Category News Views 346

Exploring North America's Last Mile Delivery Growth and Trends The last mile delivery market in North America is poised for significant growth over the next few years. Experts estimate that this market could expand by USD 14.9 billion between 2025 and 2029. This impressive growth is being driven primarily by the increasing demand for business-to-consumer (B2C) e-commerce....

Continue Reading
Mastercard Marks 20 Years on NYSE with Digital Shift

Updated Category News Views 39

A Landmark Moment at the NYSE for Mastercard Ah, another day in the whirlwind of the stock universe, where birthdays are celebrated with the finesse of boardroom discussions. Mastercard (NYSE: MA) is taking a well-deserved spotlight as it cheers two decades since it hit the seal of the New York Stock Exchange. Back on May 26th, it wasn't just business as usual. Nope, they...

Continue Reading
Insights into the Expanding Network of China-Europe Freight Trains

Updated Category News Views 236

The Rise of China-Europe Freight Trains Recently, a significant milestone was reached when the 110,000th China-Europe freight train departed from Jiaozhou Station, fully loaded with various goods such as electronic displays and household appliances. This service has now transported goods worth over USD 450 billion, showcasing its crucial role in global trade. The Journey...

Continue Reading
Netflix Investors Encouraged to Report Losses Amid Investigation

Updated Category News Views 217

Investigation Focus on Netflix, Inc. (NASDAQ: NFLX) Recently, significant scrutiny has emerged surrounding Netflix, Inc. (NASDAQ: NFLX), as Edelson Lechtzin LLP, a prominent national law firm known for handling class action lawsuits, initiates an investigation into potential violations of federal securities laws. This inquiry seeks to determine whether Netflix and certain...

Continue Reading